Skip to content

Clinical trials

Completed Carcinoma, Transitional Cell trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Status: Completed Country / region: Belgium Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20083
20131
20151
20163
20172
20183
20193
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
Hoffmann-La Roche2
Incyte Corporation2
Nektar Therapeutics2
Acrotech Biopharma Inc.1
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie1
Bayer1
Cliniques universitaires Saint-Luc- Université Catholique de Louvain1
Daiichi Sankyo1
EMD Serono Research & Development Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell20
Urinary Bladder Neoplasms8
Carcinoma, Non-Small-Cell Lung7
Neoplasm Metastasis6
Carcinoma, Renal Cell5
Melanoma5
Carcinoma, Hepatocellular4
Squamous Cell Carcinoma of Head and Neck4
Colorectal Neoplasms3
Small Cell Lung Carcinoma3

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.